Does pyrroloqinoline have potential as a novel therapy to prevent oxidative stress and mitochondrial dysfunction under conditions of sepsis?

Helen F. Galley, Damon A. Lowes and Nigel R. Webster. Division of Applied Medicine School of Medicine and Dentistry University of Aberdeen.

Funded by the Anaesthetic Research Society Heath Family Project Grant Background

Around 37,000 people die from sepsis each year in the UK. Despite the the Surviving Sepsis Campaign, the mortality rate remains at 31% for sepsis overall and 70% in patients who go on to develop multiple organ failure. Sepsis is essentially a dysregulated massive inflammatory response with release of cytokines, oxidative stress and mitochondrial dysfunction. Reactive oxygen species (ROS) are generated as by-products of the four electron reduction of molecular oxygen to water during the production of ATP. ROS can be damaging so their activity is normally tightly regulated by a collaborative network of . When defences are overwhelmed, oxidative stress results, which can cause damage to lipids, proteins, and nucleic acids, both within mitochondria and cells. Oxidative stress, inflammation and mitochondrial dysfunction are the hallmarks of sepsis [1] and the potential for benefit from antioxidants acting specifically in mitochondria has been recognised in several recent reviews [2,3,4].

We have shown that antioxidants which act within mitochondria are more effective at reducing oxidative damage caused by sepsis than antioxidants which do not specifically protect mitochondria [5,6,7]. Melatonin, for example, is highly lipophilic and can reach all cellular compartments with the highest levels in mitochondria. We have shown that melatonin and its metabolites reduce cytokine levels, oxidative stress and mitochondrial dysfunction in cells treated with lipopolysaccharide (LPS) and peptidoglycan G (PepG) to mimic conditions similar to those seen in sepsis [6]. In an LPS/PepG rat model of sepsis we also showed that melatonin reduced organ dysfunction and interleukin (IL)-6 release, improved mitochondrial dysfunction and decreased oxidative stress [5]. Melatonin treatment also resulted in lower mortality in animal models of sepsis [reviewed in 8].

PQQ is a water-soluble quinone which is an oxidoreductase co- synthesised by bacteria and is present in foods of plant origin [9]. Although PQQ is not synthesised in mammals it is rapidly absorbed by the large intestine after oral administration, and the trace levels of PQQ found in human tissues are thought to be derived from the diet. PQQ is a potent antioxidant, scavenging superoxide and hydroxyl radicals and inhibiting lipid peroxidation [10]. In animal models, PQQ protected tissues against hypoxic/ischaemic injury [11], carrageenan-induced inflammation [10], liver damage caused by ethanol [12] or carbon tetrachloride [13]. These protective effects of PQQ seem to be generally attributed to its antioxidant properties [10,14], but the precise mechanisms are unclear.

Animals devoid of PQQ in the diet have substantially lower mitochondrial numbers than animals fed high doses of PQQ [15] and administration of PQQ was reported to stimulate mitochondrial biogenesis in in vivo disease models of oxidative stress [16], enhance mitochondrial complex I activity and prevent the effects of complex I inhibitors [17]. The balance between autophagy –the ‘recycling’ pathway which removes damaged mitochondria, and biogenesis of new mitochondria is crucial for restoration of cellular homeostasis during sepsis. Mitochondrial biogenesis is controlled via the action of the transcription factor pCREB on the peroxisome proliferator-activated receptor-- coactivator-1(PGC-1) [18]. PGC-1 is a transcriptional co-activator that induces mitochondrial biogenesis, up-regulates metabolic function independent of biogenesis, and enhances mitochondrial antioxidant defences by binding to the nuclear respiratory factors that activate mitochondrial transcription factors. Previous studies have shown that PQQ can activate pCREB/PGC-1[16]. However it is not known whether PQQ specifically protects within mitochondria and whether PQQ may represent a more effective alternative to melatonin under conditions of sepsis.

The aim of this study was to assess the effect of a range of concentrations of PQQ on mitochondrial function and PCG1 expression under conditions mimicking sepsis. An endothelial ex vivo model of sepsis was established using human plasma which had been exposed to a range of inflammatory mediators.

Methods After obtaining approval from the University of Aberdeen College of Life Sciences and Medicine Ethics Review Board, healthy volunteers were invited to donate blood by advertising. Subjects were excluded if they were smokers or took any regular medication or had an existing chronic health condition. A single venous blood sample (50ml) was collected into lithium-heparin tubes then centrifuged. The plasma layer was removed and replaced with an equal volume of pre-warmed RPMI 1640 cell culture medium with and without 2µg/mL lipopolysaccharide (LPS, E.coli, strain O55:B5), 20µg/mL peptidoglycan (PepG, S. Aureus, strain 6571), 10 µg/mL lipoteichochic acid (LTA, S. Aureus), 7ng/ml flagellin (S. Typhimurium) and 10 µg/mL bacterial DNA (E. coli, strain B) to mimic sepsis like conditions. Plasma was incubated for 3h at 37oC before the addition of 2mM ATP, pH7.4 and a further 3h incubation. Cellular components were then separated by centrifugation and the supernatant (termed ‘septic plasma’) was removed and used immediately for downstream cellular assays or frozen for subsequent cytokine/nitrite analysis to assess the extent of the inflammatory status. Cytokine profiles were obtained using the Proteome profiler human cytokine array panel A (R&D Systems, Paisley, UK) and nitrite formation was measured using the Greiss assay.

HUVEC-C human endothelial cells (ATCC/LGC Standards Ltd., UK) were maintained in RPMI 1640 medium containing 10% foetal bovine serum (FBS, Biosera, UK), 50 μg/mL gentamycin (Lonza, UK) and 2.5 μg/mL amphotericin B (Sigma, UK) in a humidified atmosphere of 5% CO2 / 95% air at 37°C. HUVEC were treated with untreated or ‘septic plasma’ with a range of PQQ concentrations (1-30M) for up to 3 days. HUVEC cell viability was determined using the acid phosphatase activity assay. Mitochondrial membrane potential was assessed using the fluorescent dye 5,5,6,6-tetrachloro-1,1,3,3- tetraethyl-benzimidazolcarbocyanine iodide (JC-1). Mitochondrial metabolic activity was measured using AlamarBlueTM. and mitochondrial number was established using Mitotracker green. Total was measured using monochlorobimane as a measure of total oxidative stress. Protein expression of PGC1 was determined using standard western blotting techniques. Six independent experiments were performed using pooled plasma from 4 donors (n=6). Data are presented as box and whisker plots showing median, interquartile range (IQR) and full range. Individual data points are shown when n<6. No assumptions were made about data distribution and statistical analysis was performed using Kruskal-Wallis analysis with post hoc Mann Whitney U test as appropriate. A p-value of <0.05 was considered to be significant. Results Septic plasma Characterisation of the ‘septic plasma’ using cytokine array analysis revealed increased concentrations of a large number of cytokines and chemokines (Figure 1). Nitrite formation was also markedly increased (Figure 2).

Figure 1.

Cytokine array data from human endothelial cells exposed to ‘septic plasma’. Individual data points showing signal intensity relative to control (non-septic) plasma, n=4.

Figure 2.

Nitrite production as an indication of nitric oxide production in human endothelial cells exposed to ‘septic plasma’. Individual data points shown, n=3.

Oxidative stress

Exposure of endothelial cells to ‘septic plasma’ resulted in significant loss of cellular reduced glutathione (0.18 [0.13-0.22] units compared with 0.60 [0.53-0.66], median [range], n=6, p<0.0001, Mann Whitney U test). Treatment with PQQ at any concentration had no effect on glutathione and levels remained low (data not shown).

Mitochondrial function

Mitochondrial membrane potential was significantly lower when endothelial cells were exposed to the ‘septic plasma in the absence of PQQ. There was a dose dependent restoration of membrane potential in cells treated with PQQ (Figure 3).

Figure 3.

Mitochondrial membrane potential in human endothelial cells exposed to ‘septic plasma’. Median, interquartile and full range shown, n=6. P value shown is Kruskall Wallis across PQQ groups. * = significantly lower than control (non-septic plasma), Mann Whitney U test.

Mitochondrial metabolic activity was unchanged when endothelial cells were exposed to the ‘septic plasma’ in the absence of PQQ and there was further dose dependent decrease in metabolic activity in cells treated with PQQ (Figure 4).

Figure 4.

Mitochondrial metabolic activity in human endothelial cells exposed to ‘septic plasma’. Median, interquartile and full range shown, n=6. P value shown is Kruskall Wallis across PQQ groups. * = significantly lower than control (non-septic plasma), Mann Whitney U test.

Mitochondrial density was unchanged in endothelial cells exposed to the ‘septic plasma’ in the absence of PQQ compared to control (cells treated with non-septic plasma). In cells treated with the highest concentrations of PQQ, mitochondrial density was higher than control cells (Figure 5).

Figure 5.

Mitochondrial density in human endothelial cells exposed to ‘septic plasma’. Median, interquartile and full range shown, n=6. P value shown is Kruskall Wallis across PQQ groups. * = significantly higher than control (non-septic plasma), Mann Whitney U test.

The increases in mitochondrial density were matched by increases in PCG1 protein expression, shown in Figure 6.

Figure 6.

PGC1 protein expression from human endothelial cells exposed to ‘septic plasma’. Individual data points shown, n=3.

Discussion

We found that stimulation of blood ex vivo with a mixture of bacterial derived immune system activators to mimic human sepsis produced a pro-inflammatory milieu consistent with human sepsis, with up-regulation of 19 key cytokines and chemokines and markedly increased nitrite production. Human endothelial cells exposed to the ‘septic plasma’ exhibited loss of mitochondrial membrane potential but no change in metabolic activity and no change in mitochondrial density. Exposure of cells to PQQ improved membrane potential but worsened metabolic activity. PQQ also resulted in increased mitochondrial density, which was matched by increased protein expression of PGC1.

Many studies have shown that mitochondria are the primary targets during sepsis due to excessive reactive oxygen and nitrogen species formation, causing a loss in ATP production that contributes to mitochondrial damage and may link to organ failure [1]. Endothelial cells are particularly important in sepsis as they line the vasculature of every organ system, and produce and respond to mediators of inflammation [19]. They have a role in regulation of leucocyte adhesion and extravasation to sites of injury and inflammation, regulate permeability, and control coagulation pathways. Thus, endothelial cells provide a relevant model for examination under conditions of sepsis in vitro and to assess the effect of interventions. PQQ is a water-soluble quinone which is synthesised by bacteria and is present in foods of plant origin [9,20] and has been shown to be a potent antioxidant [10-14,20], but the precise cellular location of its action is unknown.

Increased mitochondrial biogenesis has been associated with survival in human sepsis under the control of PGC-1 pathways [18,21]. It has been shown that administration of PQQ to animals stimulates mitochondrial biogenesis via the pCREB/PGC-1 pathway [16] and increases metabolic activity in vivo [17]. PGC-1 is a transcriptional co-activator that induces mitochondrial biogenesis and also up-regulates metabolic function independent of biogenesis and can enhance mitochondrial antioxidant defences by binding to the nuclear respiratory factors that activate a variety of mitochondrial transcription factors [18,22].

Immune cell activation in response to pathogens can result in uncontrolled systemic inflammation in patients with sepsis. Tumour necrosis factor (TNF), interleukin (IL)-1 and IL-6 have been shown to be the main mediators influencing the pathophysiology in systemic inflammation. In this study, the levels of TNF, IL-1 and 6 were markedly increased in the septic plasm, in addition to many other inflammatory cytokines involved in immune cell recruitment, activation and oxidative stress. Analysis of septic plasma showed that it was devoid of anti-inflammatory cytokines, particularly IL-10, which has been shown to impede subsequent endothelial cell activation and as such mimics the early acute pro-inflammatory phase of human sepsis. In our study, high levels of nitrite were also detected in septic plasma ‘septic’ media, indicating activation of the inducible nitric oxide pathway. Interestingly endogenous nitric oxide has also been shown to increase mitochondrial biogenesis through PGC-1[23].

Reduced glutathione (GSH) is a tripeptide that is the predominant intracellular low- molecular-weight thiol compound. It has many important roles in the cell and helps maintain the reduced state of the sulfhydryl groups of many proteins to protect cells against oxidative stress. Cellular glutathione levels are altered in inflammatory conditions including sepsis. In our study we showed that there was substantial loss of GSH following exposure to ‘septic plasma’ but treatment with PQQ did not ameliorate this loss, suggesting that the profound intracellular oxidative stress was in excess of the antioxidant potential of PQQ, perhaps due to the site of action of PQQ.

The mechanism of sepsis induced mitochondrial dysfunction includes physical damage to the mitochondria, inhibition of the electron transport chain , decreased mitochondrial activity, and down-regulation of mitochondrial protein expression. In our study we examined several aspects of mitochondrial function including mitochondrial membrane potential and metabolic activity. Exposure of the endothelial cells to the ‘septic plasma’ resulted in a loss of mitochondrial membrane potential, which was ameliorated by PQQ. Similarly, mitochondrial metabolic activity was markedly reduced following exposure of endothelial cells to ‘septic plasma’ and treatment of the cells with PQQ resulted in further reduction of metabolic activity in a dose dependent manner. We have seen similar findings in endothelial cells treated with LPS and PepG. Recovery from sepsis may depend on restoration of normal mitochondrial function [22]. Studies from animal models and patients with sepsis show histological recovery of mitochondria after a septic insult, which precedes clinical improvement [21,22]. It has been shown that PQQ can induce mitochondrial biogenesis by the activation of PGC1 pathways under conditions of oxidative stress. PGC1 is regarded as the ‘master regulator’ of mitochondrial function, not only enhancing mitochondrial biogenesis, but also inducing transcription factors responsible for the up-regulation of metabolic respiration in addition to inducing an antioxidant response by regulating production of mitochondrial small molecular weight thiols (GSH and thioredoxin) and associated enzyme systems [18,22]. We found that mitochondrial density was unchanged in cells exposed to ‘septic plasma’ and treatment with 10 or 30M PQQ further augmented mitochondrial density. Analysis of protein expression of PGC1 showed an increase in PGC1 protein expression which matched the increases in mitochondrial density.

Summary Activation of blood ex vivo with bacterially derived stimuli resulted in a cytokine milieu similar to that seen in the acute phase of human sepsis. PQQ failed to prevent the loss of GSH that indicated a profound intracellular oxidative stress, but protected against the loss of mitochondrial membrane potential, whilst worsening metabolic activity. Mitochondrial density was significantly increased at the highest concentrations of PQQ which was reflected by increased PGC1protein expression.

References 1. Garrabou C, Lopez S, Tobias E, Cardellach F, Miro O, Casademont J. The effect of sepsis on mitochondria. J Infect Dis. 2012; 205: 392-400 2. Galley HF. Bench-to-bedside review: Targeting antioxidants to mitochondria in sepsis. Crit Care, 2010; 14: 230 3. Víctor VM, Espulgues JV, Hernández-Mijares A, Rocha M. Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants. Infect Disord Drug Targets 2009; 9: 376-89. 4. Milagros R, Herance R, Rovira S, Hernandez-Mijares A, Victor VM. Mitochondrial dysfunction and antioxidant therapy in sepsis. Infec Dis Drug Targ 2012; 12: 1871-5265. 5. Lowes DA, Webster NR, Murphy MP, Galley HF. Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis. Br J Anaes 2013; 110: 472-80 6. Lowes DA, Almawash AM, Webster NR, Reid VL, Galley HF. Melatonin and structurally similar compounds have differing effects on inflammation and mitochondrial function in endothelial cells under conditions mimicking sepsis. Br J Anaes 2011; 107: 193-201 7. Lowes DA, Thottakam BMV, Webster NR, Murphy MJ, Galley HF. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Rad Biol Med 2008; 45: 1559-65 8. Srinivasan V, Pandi-Perumal SR, Spence DW, Kato H, Cardinali DP. Melatonin in septic shock: some recent concepts. J Crit Care 2010; 25: 656-61 9. He K, Nukada H, Urakami T, Murphy MP. Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems. Biochem Pharmacol 2003; 65: 67–74 10. Hamagishi Y, Murata S, Kamei H, Oki T, Adachi O, Ameyama M. New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema. J Pharmacol Exp Ther 1990; 255: 980–5 11. Jensen FE, Gardner GJ, Williams AP, Gallop PM, Aizenman E, Rosenberg PA. The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury. Neuroscience 1994; 62: 399–406 12. Hobara N, Watanabe A, Kobayashi M, Tsuji T, Gomita Y, Araki Y. Quinone derivatives lower blood and liver acetaldehyde but not ethanol concentrations following ethanol loading to rats. Pharmacol 1988; 37: 264–7 13. Stites TE, Mah J, Fluckiger R, Paz MA, Gallop PM, Rucker RB. Dietary deficiency of pyrroloquinoline quinone (PQQ) alters mitochondrial function in young mice. FASEB J 1996; 10: A800. 14. Bishop A, Gallop PM, Karnovsky ML. Pyrroloquinoline quinone: a novel ? Nutr Rev 1998; 56: 287–93 15. Tchaparian E, Marshal L, Cutler G, Bauerly K, Chowanadisai W, Satre M, Harris C, Rucker RB. Identification of transcriptional networks responding to pyrroloquinoline quinone dietary supplementation and their influence on thioredoxin expression, and the JAK/STAT and MAPK pathways. Biochem J 2010; 429: 515–26 16. Chowanadisai W, Bauerly KA, Tchaparian E, Wong A, Cortopassi GA, Rucker RB. Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC- 2009; 285: 142-52 17. Stites T, Storms D, Bauerly K, Mah J, Harris C, Fascetti A, Rogers Q, Tchaparian E, Satre M, Rucker RB. Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. J Nutr 2006; 136: 390–6 18. Ventura-Clapier R, Garnier A, Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc Res. 2008;79:208–17 19. Galley HF, Webster NR. Physiology of the endothelium. Br J Anaesth 2004; 93: 105-13. 20. Misra HS, Rajpurohit YS, Khairnar NP. Pyrroloquinoline-quinone and its versatile roles in biological processes. J Biosci 2012; 37: 313–25 21. Carré JE, Orban J-C, Re L, Felsmann K, Iffert W, Bauer M, Suliman HB, Piantadosi CA, Mayhew TM, Breen P, et al. Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med. 2010;182:745–51. 22. Singer M.The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence 2014; 5: 66-72. 23. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moncada S, et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science.2003;299:896–9.

Dissemination

Presentation at the Anaesthetic Research Society meeting October 2014, in London/

Publication in abstract form:

Galley HF, Lowes DA, Webster NR. The effect of pyrroloqinoline quinone (PQQ) on mitochondria under conditions of sepsis. Br J Anaesth (in press).